封面
市場調查報告書
商品編碼
1373928

Alpha發射體市場,按放射性核種類型、按應用、最終用戶、國家和地區 - 2023-2030年行業分析、市場規模、市場佔有率和預測

Alpha Emitter Market, By Type of Radionuclide, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年Alpha發射體市場規模為 4.1687 億美元,2023年至2030年CAGR為 12.6%。

治療方法可能包括使用專門的抗發炎藥物,以及目的是擴大肺部空氣通道的創新支氣管擴張技術。此外,患者通常受益於目的是促進黏液清除的標靶藥物,這在減輕症狀嚴重程度和防止病情惡化方面發揮著非常重要的作用。治療計劃經過精心設計,以滿足每位患者的特定要求,主要致力於症狀管理、預防發作和最佳化肺功能。這種解決支氣管火焰的綜合方法可確保受影響的個人能夠改善呼吸系統健康,並過著更充實的生活。

Alpha發射體市場-市場動態

人們對這種經常被低估的疾病的認知不斷提高,推動了市場需求

隨著醫學知識和診斷工具的進步,人們越來越認知到支氣管擴張病例。此外,人口老化和慢性呼吸道疾病的激增增加了對更有效治療的需求。這種意識的提高和患者群體的擴大促使製藥公司和研究人員投資於支氣管擴張護理的開創性解決方案,包括開發創新藥物。這些努力背後的關鍵驅動力是尋求提高支氣管擴張患者的生活品質,減輕復發症狀和感染的負擔。

Alpha發射體市場 - 關鍵見解

根據研究分析師的評估,全球Alpha發射體產業預計在2023年至2030年的預測期內年成長率約為 12.6%。

Alpha發射體產業有望大幅擴張,這主要是由於人們越來越認知到這種經常被診斷不足的疾病。

在放射性核種類別中,鐳(Ra-223)預計在2022年佔據最大的市場佔有率。

從應用細分來看,骨轉移在2022年放射性核種類型中排名第一。

從地理位置來看,北美將成為2022年收入的主要來源。

Alpha發射體市場 - 細分分析:

全球Alpha發射體市場呈現全面的細分,其中包括放射性核種類型、應用、最終用戶和區域。

依放射性核種的類型,市場分為六個不同的類別:鐳(Ra-223)、錒(Ac-225)、鉛(Pb-212)、砹-211、鉍-213 等。值得注意的是,鐳(Ra-223)在這一領域處於領先地位。鐳 223(Ra-223)因其在靶向 α 粒子治療中的有效性,特別是在治療轉移性前列腺癌方面的有效性而成為備受歡迎的放射性核素。其卓越的能力能夠專門針對癌性骨組織,同時保護附近的健康細胞,這對於改善已擴散到骨骼的晚期前列腺癌患者的生活品質和生存率做出了重大貢獻。

Alpha發射體市場 - 地理洞察

從地理來看,這個市場涵蓋的地區非常廣泛,包括北美、拉丁美洲、歐洲、亞太地區以及中東和非洲。這些地區進一步細分為各國,每個國家都對商業格局做出了貢獻。

北美因其在癌症治療和核子醫學中的關鍵作用而成為Alpha發射體的重要中心。在靶向α粒子輻射中利用α發射同位素代表了一種創新的癌症治療方法,在治療多種癌症類型方面具有巨大潛力。

Alpha發射體市場-競爭格局:

Alpha發射體領域呈現出競爭格局,其特點是許多專門從事核醫學和放射性藥物的知名公司的存在。 Actinium Pharmaceuticals、Curium 和 Lantheus Holdings 等老牌行業領導者在醫療應用 α 發射同位素的探勘和生產方面發揮積極作用。此外,競爭背景受到新創公司和研究機構貢獻的影響,因為它們積極致力於開發基於Alpha發射體的創新藥物和診斷工具。

目錄

第1章 Alpha發射體市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘錄
    • 按放射性核種類型分類的Alpha發射體市場摘錄
    • 依應用分類的 Alpha發射體市場摘錄
    • 依最終用戶的 Alpha發射體市場摘錄
    • 依國家分類的 Alpha發射體市場摘錄
    • 依地區分類的 Alpha發射體市場摘錄
  • 競爭洞察

第3章 Alpha發射體主要市場趨勢

  • Alpha發射體市場促進因素
    • 市場促進因素的影響分析
  • Alpha發射體市場限制
    • 市場限制影響分析
  • Alpha發射體市場機會
  • Alpha發射體市場未來趨勢

第4章 Alpha發射體產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 Alpha發射體市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 Alpha發射體市場格局

  • 2022年 Alpha發射體市佔率分析
  • 細分資料:按主要製造商
    • 既有參與者分析
    • 新興參與者分析

第7章 Alpha發射體市場 - 按放射性核種類型

  • 概述
    • 按放射性核種類型分類的細分市場佔有率分析
    • 鐳(Ra-223)
    • 錒(Ac-225)
    • 鉛(Pb-212)
    • 砈-211
    • 鉍213
    • 其他

第8章 Alpha發射體市場 -依應用

  • 概述
    • 依應用的細分市場佔有率分析
    • 骨轉移
    • 攝護腺癌
    • 神經內分泌腫瘤
    • 卵巢癌
    • 其他

第9章 Alpha發射體市場 - 依最終用戶

  • 概述
    • 依最終用戶分類的細分市場佔有率分析
    • 醫院
    • 專科診所
    • 診斷中心
    • 其他

第10章 Alpha發射體市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美Alpha發射體主要製造商
    • 北美市場規模和預測(依國家)
    • 北美市場規模和預測(依放射性核種類型)
    • 北美市場規模和預測(依應用)
    • 北美市場規模和預測(依最終用戶)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲Alpha發射體主要製造商
    • 歐洲市場規模和預測(依國家)
    • 歐洲市場規模和預測(依放射性核種類型)
    • 歐洲市場規模和預測(依應用)
    • 歐洲市場規模和預測(依最終用戶)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區(APAC)
    • 概述
    • 亞太地區Alpha發射體主要製造商
    • 亞太地區市場規模與預測(依國家)
    • 亞太地區市場規模和預測(依放射性核種類型)
    • 亞太地區市場規模與預測(依應用)
    • 亞太地區市場規模和預測(依最終用戶)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲Alpha發射體主要製造商
    • 拉丁美洲市場規模與預測(依國家)
    • 拉丁美洲市場規模和預測(依放射性核種類型)
    • 拉丁美洲市場規模與預測(依應用)
    • 拉丁美洲市場規模和預測(依最終用戶)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲Alpha發射體主要製造商
    • 中東和非洲市場規模及預測(依國家)
    • 中東和非洲市場規模及預測(依放射性核種類型)
    • 中東和非洲市場規模及預測(依應用)
    • 中東和非洲市場規模和預測(依最終用戶)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第11章 主要供應商分析 - Alpha發射體產業

  • 競爭儀表板
  • 公司簡介
    • Actinium Pharmaceutical Inc.
    • Alpha Tau Medical Ltd
    • Bayer AG
    • Bracco
    • Cardinal Health
    • Eckert & Ziegle
    • Fusion Pharmaceuticals
    • IBA Worldwide
    • NorthStar Medical Radioisotopes(NMR)
    • Orano Group
    • Viewpoint Molecular Targeting
    • RadioMedix
    • Telix Pharmaceuticals Limited.
    • TerraPower, LLC
    • NIOWAVE Inc.
    • IONETIX Corporation.

第12章 360 度分析師視角

第13章 附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1806

REPORT HIGHLIGHT

Alpha Emitter Market size was valued at USD 416.87 Million in 2022, expanding at a CAGR of 12.6% from 2023 to 2030.

Alpha emitter medicines have proven effective in addressing the challenges of a rare autoimmune disorder known as "Bronchial Blaze." This condition is characterized by the abnormal inflammation and constriction of the bronchial tubes, which can result in debilitating symptoms such as persistent breathlessness, chronic coughing, and frequent pulmonary flare-ups. The treatment regimen for Bronchial Blaze involves a multifaceted approach tailored to the individual needs of each patient. This approach prioritizes alleviating symptoms, minimizing the risk of recurring episodes, and enhancing overall lung function to enhance the quality of life for those afflicted by this condition.

Therapies may include the administration of specialized anti-inflammatory agents, as well as innovative bronchodilation techniques aimed at expanding the air passages within the lungs. Additionally, patients often benefit from targeted medications designed to promote mucus clearance, which plays a crucial role in reducing the severity of symptoms and preventing exacerbations. The treatment plan is meticulously crafted to cater to each patient's specific requirements, with a primary focus on symptom management, prevention of flare-ups, and the optimization of lung function. This comprehensive approach to addressing Bronchial Blaze ensures that affected individuals can lead more fulfilling lives with improved respiratory health.

Alpha Emitter Market- Market Dynamics

Rising awareness of this often-underdiagnosed condition propel market demand

With advancements in medical knowledge and diagnostic tools, there is a growing recognition of bronchiectasis cases. Additionally, an aging demographic and the surge in chronic respiratory conditions have amplified the demand for more effective treatments. This heightened awareness and the expanding patient population have spurred pharmaceutical companies and researchers to invest in pioneering solutions for bronchiectasis care, including the development of innovative pharmaceuticals. A pivotal driving force behind these efforts is the quest to enhance the quality of life for bronchiectasis patients, lessening the burden of recurrent symptoms and infections.

Alpha Emitter Market- Key Insights

According to our research analyst's assessment, the global Alpha Emitter industry anticipates an annual growth rate of approximately 12.6% throughout the forecast period spanning from 2023 to 2030.

The Alpha Emitter sector is poised for substantial expansion, largely driven by the increasing recognition of a condition that often goes underdiagnosed.

Within the Radionuclide category, Radium (Ra-223) is expected to exhibit the most significant market share in the year 2022.

In terms of application breakdown, Bone Metastases claimed the top position among Radionuclide types in 2022.

Geographically, North America emerged as the primary source of revenue generation in the year 2022.

Alpha Emitter Market- Segmentation Analysis:

The Global Alpha Emitter Market exhibits a comprehensive segmentation, which encompasses Type of Radionuclide, Application, End User, and Region.

When considering the Type of Radionuclide, the market branches into six distinct categories: Radium (Ra-223), Actinium (Ac-225), Lead (Pb-212), Astatine-211, Bismuth-213, and Others. Notably, Radium (Ra-223) takes the lead in this segmentation. Radium-223 (Ra-223) stands out as a highly sought-after radionuclide due to its effectiveness in targeted alpha-particle therapy, particularly in the treatment of metastatic prostate cancer. Its remarkable ability to specifically target cancerous bone tissue while safeguarding healthy cells in the vicinity contributes significantly to improving the quality of life and survival rates for patients dealing with advanced prostate cancer that has spread to the bones.

Alpha Emitter Market- Geographical Insights

From a geographical perspective, this market encompasses a wide range of regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further subdivided into individual countries, each contributing to the business landscape.

North America stands out as a significant hub for Alpha emitters due to their crucial role in cancer therapy and nuclear medicine. The utilization of alpha-emitting isotopes in targeted alpha-particle radiation represents an innovative approach to cancer treatment, holding great potential for addressing a variety of cancer types.

Alpha Emitter Market- Competitive Landscape:

The arena of alpha emitters presents a competitive landscape marked by the presence of numerous prominent companies specializing in nuclear medicine and radiopharmaceuticals. Established industry leaders such as Actinium Pharmaceuticals, Curium, and Lantheus Holdings play active roles in the exploration and production of alpha-emitting isotopes for medical applications. Furthermore, the competitive backdrop is influenced by the contributions of startups and research institutions, as they actively contribute to the development of inventive pharmaceuticals and diagnostic tools based on alpha emitters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ALPHA EMITTER MARKET KEY PLAYERS

  • Actinium Pharmaceutical Inc.
  • Alpha Tau Medical Ltd
  • Bayer AG
  • Bracco
  • Cardinal Health
  • Eckert & Ziegle
  • Fusion Pharmaceuticals
  • IBA Worldwide
  • NorthStar Medical Radioisotopes (NMR)
  • Orano Group
  • Viewpoint Molecular Targeting
  • RadioMedix
  • Telix Pharmaceuticals Limited.
  • TerraPower, LLC
  • NIOWAVE Inc.
  • IONETIX Corporation

GLOBAL ALPHA EMITTER MARKET, BY TYPE OF RADIONUCLIDE

  • Radium (Ra-223)
  • Actinium (Ac-225)
  • Lead (Pb-212)
  • Astatine-211
  • Bismuth-213
  • Others

GLOBAL ALPHA EMITTER MARKET, BY APPLICATION

  • Bone Metastases
  • Prostate Cancer
  • Neuroendocrine Tumors
  • Ovarian Cancer
  • Others

GLOBAL ALPHA EMITTER MARKET, BY END USER

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Others

GLOBAL ALPHA EMITTER MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Alpha Emitter Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Alpha Emitter Market Snippet by Type of Radionuclide
    • 2.1.2. Alpha Emitter Market Snippet by Application
    • 2.1.3. Alpha Emitter Market Snippet by End User
    • 2.1.4. Alpha Emitter Market Snippet by Country
    • 2.1.5. Alpha Emitter Market Snippet by Region
  • 2.2. Competitive Insights

3. Alpha Emitter Key Market Trends

  • 3.1. Alpha Emitter Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Alpha Emitter Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Alpha Emitter Market Opportunities
  • 3.4. Alpha Emitter Market Future Trends

4. Alpha Emitter Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Alpha Emitter Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Alpha Emitter Market Landscape

  • 6.1. Alpha Emitter Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Alpha Emitter Market - By Type of Radionuclide

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type of Radionuclide, 2022 & 2030 (%)
    • 7.1.2. Radium (Ra-223)
    • 7.1.3. Actinium (Ac-225)
    • 7.1.4. Lead (Pb-212)
    • 7.1.5. Astatine-211
    • 7.1.6. Bismuth-213
    • 7.1.7. Others

8. Alpha Emitter Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Bone Metastases
    • 8.1.3. Prostate Cancer
    • 8.1.4. Neuroendocrine Tumors
    • 8.1.5. Ovarian Cancer
    • 8.1.6. Others

9. Alpha Emitter Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Specialty Clinics
    • 9.1.4. Diagnostic Centers
    • 9.1.5. Others

10. Alpha Emitter Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Alpha Emitter Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Alpha Emitter Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Alpha Emitter Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Alpha Emitter Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Alpha Emitter Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Alpha Emitter Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Actinium Pharmaceutical Inc.
    • 11.2.2. Alpha Tau Medical Ltd
    • 11.2.3. Bayer AG
    • 11.2.4. Bracco
    • 11.2.5. Cardinal Health
    • 11.2.6. Eckert & Ziegle
    • 11.2.7. Fusion Pharmaceuticals
    • 11.2.8. IBA Worldwide
    • 11.2.9. NorthStar Medical Radioisotopes (NMR)
    • 11.2.10. Orano Group
    • 11.2.11. Viewpoint Molecular Targeting
    • 11.2.12. RadioMedix
    • 11.2.13. Telix Pharmaceuticals Limited.
    • 11.2.14. TerraPower, LLC
    • 11.2.15. NIOWAVE Inc.
    • 11.2.16. IONETIX Corporation.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Applications
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Alpha Emitter Market: Type of Radionuclide Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type of Radionuclide
  • TABLE Global Alpha Emitter Market, by Type of Radionuclide 2018-2030 (USD Million)
  • TABLE Alpha Emitter Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Alpha Emitter Market, by Application 2018-2030 (USD Million)
  • TABLE Alpha Emitter Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Alpha Emitter Market, by End User 2018-2030 (USD Million)
  • TABLE Alpha Emitter Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Alpha Emitter Market, by Region 2018-2030 (USD Million)
  • TABLE North America Alpha Emitter Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Alpha Emitter Market, by Type of Radionuclide, 2018-2030 (USD Million)
  • TABLE North America Alpha Emitter Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Alpha Emitter Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Alpha Emitter Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Alpha Emitter Market, by Type of Radionuclide, 2018-2030 (USD Million)
  • TABLE Europe Alpha Emitter Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Alpha Emitter Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Alpha Emitter Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Alpha Emitter Market, by Type of Radionuclide, 2018-2030 (USD Million)
  • TABLE Asia Pacific Alpha Emitter Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Alpha Emitter Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Alpha Emitter Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Alpha Emitter Market, by Type of Radionuclide, 2018-2030 (USD Million)
  • TABLE Latin America Alpha Emitter Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Alpha Emitter Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Alpha Emitter Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Alpha Emitter Market, by Type of Radionuclide, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Alpha Emitter Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Alpha Emitter Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Alpha Emitter Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type of Radionuclide segment market share analysis, 2022 & 2030
  • FIGURE Type of Radionuclide segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Alpha Emitter Market share and leading players, 2022
  • FIGURE Europe Alpha Emitter Market share and leading players, 2022
  • FIGURE Asia Pacific Alpha Emitter Market share and leading players, 2022
  • FIGURE Latin America Alpha Emitter Market share and leading players, 2022
  • FIGURE Middle East and Africa Alpha Emitter Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Alpha Emitter Market share analysis by country, 2022
  • FIGURE Germany Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Alpha Emitter Market share analysis by country, 2022
  • FIGURE India Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Alpha Emitter Market share analysis by country, 2022
  • FIGURE Brazil Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Alpha Emitter Market share analysis by country, 2022
  • FIGURE Saudi Arabia Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)